Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Chimerix Announces Top Line Data From CMX001 Phase 2 Adenovirus Study and Late-Breaker Presentation at ICAAC DURHAM, N.C., Aug. 14, 2013 -- Chimerix, Inc. , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, ... (more)
http://www.biospace.com/news_story.aspx?StoryID=305853&full=1
http://www.biospace.com/news_story.aspx?StoryID=305853&full=1
No comments:
Post a Comment